TCM
RPRX icon

TimesSquare Capital Management’s Royalty Pharma RPRX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,257,195
Closed -$38.6M 174
2023
Q2
$38.6M Sell
1,257,195
-10,635
-0.8% -$327K 0.55% 76
2023
Q1
$45.7M Sell
1,267,830
-278,230
-18% -$10M 0.67% 60
2022
Q4
$61.1M Sell
1,546,060
-18,840
-1% -$745K 0.87% 36
2022
Q3
$62.9M Sell
1,564,900
-42,900
-3% -$1.72M 0.87% 27
2022
Q2
$67.6M Sell
1,607,800
-43,100
-3% -$1.81M 0.94% 22
2022
Q1
$64.3M Sell
1,650,900
-2,500
-0.2% -$97.4K 0.72% 42
2021
Q4
$65.9M Buy
1,653,400
+133,400
+9% +$5.32M 0.58% 72
2021
Q3
$54.9M Buy
1,520,000
+18,440
+1% +$666K 0.48% 84
2021
Q2
$61.5M Buy
1,501,560
+85,945
+6% +$3.52M 0.5% 81
2021
Q1
$61.7M Sell
1,415,615
-191,865
-12% -$8.37M 0.53% 76
2020
Q4
$80.5M Buy
1,607,480
+618,970
+63% +$31M 0.65% 47
2020
Q3
$41.6M Buy
988,510
+237,710
+32% +$10M 0.39% 114
2020
Q2
$36.5M Buy
+750,800
New +$36.5M 0.35% 132